First Healthcare Center Targeted to Injection Drug Users Opens in New York

Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.

First Healthcare Center Targeted to Injection Drug Users Opens in New York

TB & Outbreaks Week (12.24.02) - Friday, December 27, 2002

Positive Health Project, a New York syringe exchange program, and Diversified Health Systems Management Inc. recently announced the opening of Positive Health Care, the nation's first comprehensive health care center targeting high-risk clients, including current and former injection drug users. Although New York City encompasses only 3 percent of the US population, the city claims 16 percent of all US AIDS cases. Of the 4,000-6,000 new HIV/AIDS cases reported in New York City in 2000, 39 percent of those infections are attributable to injection drug use.

Targeted to injection drug users, PHC is founded on the principles of harm reduction. It provides patients with primary medical care, dentistry, and HIV/AIDS testing and counseling services. The center's patient base includes clients from syringe exchange programs throughout the city.

"It is our hope that by offering [patients] access to high quality and nondiscriminatory healthcare, they will begin to realize their self-worth and make lifestyle changes that can reduce their health risks," said Dr. Richard Gold, medical director of the center. Many injection drug users and other high- risk populations are homeless and therefore have limited access to medical services. Moreover, this population often avoids medical services for fear of legal repercussions and discrimination associated with drug addiction.
021227
AD022504

Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.